论文部分内容阅读
SLE的慢性肾衰的预后不良是有充分证据的。多年来对继发于狼疮性肾炎的终末期肾病,不常规推荐作血液透析,因为关于他们的临床经过不清楚。在1973年,我们证明长期血液透析和减少免疫抑制,可有良好的短期预后。本文描述了我们在某医疗中心常规用透析和移殖治疗,由SLE引起的终末期肾病全部病人的12年经验,我们的资料着重阐述病人生存、肾脏和非肾脏疾病的临床活动性和长期的机能活动性。
The poor prognosis of chronic renal failure in SLE is well documented. End-stage renal disease secondary to lupus nephritis has not been routinely recommended for hemodialysis over the years as the clinical course of their treatment is unclear. In 1973, we demonstrated that long-term hemodialysis and immunosuppression have a good short-term prognosis. This article describes our 12-year experience with all patients with end-stage renal disease due to SLE, conventionally treated with dialysis and transplantation at a medical center. Our data highlight the clinical survival of patients with survival, renal and non-renal disease, and long-term Functional activity.